Manny Villafana to Headline MedInvest Cardiovascular and Neurovascular Investor Conference Dec 8-11 MedInvest, a leading healthcare, biotech, and medtech media and conference company, is pleased to announce the addition of Manny Villafan...
Boston Scientific to Divest BTG Specialty Pharmaceuticals Business MARLBOROUGH, Mass., Dec. 1, 2020 /PRNewswire/ -- Boston Scientific Corporation announced that it has entered into a definitive agreement w...
Cardiac Insight: Leading the Revolution in ECG Monitoring and Analysis Pairing intelligent, “clinically aware” expert algorithms that automate medical decision-support analytics with unobtrusive but sophistic...
MedInvest Cardiovascular & Neurovascular Conference Virtual Conference Headlined by St. Jude Founder MedInvest, a leading healthcare, biotech, and medtech media and conference company, announced that it will host a virtual investor confer...
Boston Scientific (NYSE:BSX) Shares Fell over 3% Following the Release of SCOPE II Trial Data at TCT Boston Scientific (NYSE:BSX) shares fell over 3% following the release of SCOPE II trial data at TCT Connect 2020. The data showed that ...
Promaxo: Revolutionizing the MRI Industry The Magnetic Resonance Imaging (MRI) patient flow process has historically been highly inefficient. Physician offices rarely have MRI ma...
Boston Scientific Launches ACURATE Neo2™ Aortic Valve System in Europe Boston Scientific Corporation (NYSE: BSX) today, September 28, announced it has initiated a controlled launch of its ACURATE neo2™ Aortic...
St. Jude Founder to Headline MedInvest Cardiovascular Investor Conference Scheduled for Dec 8-11 MedInvest, a leading healthcare, biotech, and medtech media and conference company, announced that it will host a virtual investor confer...
Medtronic Received FDA Breakthrough Device Designation for TYRX Driveline Wrap Device Medtronic plc (NYSE:MDT) announced on Tuesday, September 22 that it had received Breakthrough Device Designation status from the U.S. Foo...
National Foundation for Cancer Research AIM-HI Women’s Venture Competition - Live Stream The National Foundation for Cancer Research’s (NFCR) AIM-HI Accelerator Fund will be hosting the final round of its Women’s Venture Compe...
CosmoAesthetics Publishes Success in Using LLLT to Treat COVID-19 Inflammation CosmoAesthetics, an Australian based innovation hub, recently announced that its external laser technology may provide benefit in the tre...
Market Update: 2020 Biotechnology and Pharma Funding Set to Exceed 2019 Despite COVID-19 Crisis Despite significant and growing market risk – including a Presidential election, the COVID crisis and a resulting downturn in economic ou...
Executive Coach's Corner: 5 Quick Tips to Manage Stress in a Period of Uncertainty To sign up for coaching, visit: www.hodgescoaching.com Have you ever noticed that in times of stress, you make unusual mistakes? Maybe yo...
Editor's Note and Announcement of Big Data, AI, Telemedicine, and Digital Health Conference Welcome to the inaugural issue of the MedInvest newsletter, which will be published monthly – with occasional special bi-weekly issues – ...
SciTech Advances ST-001 nanoFenretinide to Clinical Trials for SARS-CoV-2 A Detroit based clinical stage oncology-focused bio-pharmaceutical company, SciTech Development LLC, recently determined that its lead pr...
Geneius Advances A T-Cell Vaccine and Therapy Product for SARS-CoV-2 Geneius Biotechnology, Inc, a Massachusetts-based biopharmaceutical company, announced at the MedInvest Infectious Disease & Immunology C...
Moderna and Pfizer to Start Phase III Trial for COVID-19 Vaccine Moderna (MRNA) announced on Monday, July 27 that it had begun Phase III trials for its COVID-19 vaccine, a day following another announce...
